Tag: Phase 3 trial investment
Paradigm Raises $16 Million for Global Phase 3 Clinical Trial
Paradigm Biopharmaceuticals Secures $16 Million for Phase 3 Clinical TrialIn a groundbreaking development, Paradigm Biopharmaceuticals (ASX:PAR) has successfully raised $16 million for its upcoming...